Hepatobiliary excretion and enterohepatic circulation of colchicine in rats.

[1]  H. Liao,et al.  Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiation. , 2005, World journal of gastroenterology.

[2]  T. Tsai,et al.  Hepatobiliary excretion of berberine. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[3]  A. Benedetti,et al.  Effect of Pharmacological Modulation of Liver P-Glycoproteins on Cyclosporin A Biliary Excretion and Cholestasis A Study in Isolated Perfused Rat Liver , 1999, Digestive Diseases and Sciences.

[4]  T. Tsai.  Assaying protein unbound drugs using microdialysis techniques. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  M. Kaplan,et al.  Efficacy of Colchicine in Patients With Primary Biliary Cirrhosis Poorly Responsive to Ursodiol and Methotrexate , 2003, American Journal of Gastroenterology.

[6]  A. Shum,et al.  The effects of the cyclosporin A, a P‐glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study , 2002, British journal of pharmacology.

[7]  P. Yeh,et al.  Effect of P‐glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis , 2001, British journal of pharmacology.

[8]  T. Tsai.  Pharmacokinetics of pefloxacin and its interaction with cyclosporin A, a P‐glycoprotein modulator, in rat blood, brain and bile, using simultaneous microdialysis , 2001, British journal of pharmacology.

[9]  D. Breimer,et al.  Methodological issues in microdialysis sampling for pharmacokinetic studies. , 2000, Advanced drug delivery reviews.

[10]  P. Scheuer,et al.  Multicentre randomized placebo‐controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis , 2000, Alimentary pharmacology & therapeutics.

[11]  T. Tsai,et al.  Enterohepatic circulation of chloramphenicol and its glucuronide in the rat by microdialysis using a hepato-duodenal shunt. , 1999, Life sciences.

[12]  T. Yokokura,et al.  Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats , 2000, Cancer Chemotherapy and Pharmacology.

[13]  M. Klintschar,et al.  Colchicine poisoning by accidental ingestion of meadow saffron (Colchicum autumnale): pathological and medicolegal aspects. , 1999, Forensic science international.

[14]  L. King,et al.  Colchicine in dermatology. , 1998, Journal of the American Academy of Dermatology.

[15]  E. Ben-Chetrit,et al.  Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases? , 1998, Medical hypotheses.

[16]  M. Müller,et al.  Regulation of organic anion transport in the liver. , 1997, The Yale journal of biology and medicine.

[17]  S. Desrayaud,et al.  Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine. , 1997, Life sciences.

[18]  D. Meijer,et al.  Hepatobiliary elimination of cationic drugs: The role of P-glycoproteins and other ATP-dependent transporters , 1997 .

[19]  P. Souček,et al.  Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. , 1997, Biochemical pharmacology.

[20]  B. Sikic,et al.  Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein , 1997, Cancer Chemotherapy and Pharmacology.

[21]  F. Bressolle,et al.  Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics. , 1996, Journal of chromatography. B, Biomedical applications.

[22]  S. Imaoka,et al.  Induction of cytochrome P450 isozymes in rat renal microsomes by cyclosporin A. , 1994, Biochemical Pharmacology.

[23]  O. Chappey,et al.  Binding of colchicine and thiocolchicoside to human serum proteins and blood cells. , 1994, International journal of clinical pharmacology and therapeutics.

[24]  I. D. de Lannoy,et al.  Renal secretion of vinblastine, vincristine and colchicine in vivo. , 1994, The Journal of pharmacology and experimental therapeutics.

[25]  C. Bismuth,et al.  Toxicokinetics of Colchicine in Humans: Analysis of Tissue, Plasma and Urine Data in Ten Cases , 1992, Human & experimental toxicology.

[26]  J. Scherrmann,et al.  Pharmacokinetics of colchicine: a review of experimental and clinical data. , 1992, Zeitschrift fur Gastroenterologie.

[27]  M. Spino,et al.  Colchicine: A State‐of‐the‐Art Review , 1991, Pharmacotherapy.

[28]  R. Koda,et al.  Determination of the antimitotic agents N-desacetylcolchicine, demecolcine and colchicine in serum and urine. , 1990, Journal of chromatography.

[29]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Scherrmann,et al.  A sensitive radioimmunoassay for colchicine , 1980, The Journal of pharmacy and pharmacology.

[31]  J. Riordan,et al.  Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. , 1979, The Journal of biological chemistry.

[32]  C. Klaassen,et al.  Biliary excretion of colchicine. , 1975, The Journal of pharmacology and experimental therapeutics.

[33]  S. L. Stone,et al.  Aspects of bile secretion in the rabbit. , 1975, The Journal of physiology.